Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenke Feng

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
The Journal of Pathology|November 27, 2020
Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activationFengyuan Li, Cuiqing Zhao, Tuo Shao, et al.
Journal of Hepatology|May 28, 2018
Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunctionTuo Shao, Cuiqing Zhao, Fengyuan Li, et al.
Iscience|June 18, 2021
Lemon exosome-like nanoparticles enhance stress survival of gut bacteria by RNase P-mediated specific tRNA decayChao Lei, Yun Teng, Liqing He, et al.
EMBO Molecular Medicine|March 31, 2025
Liver TET1 promotes metabolic dysfunction-associated steatotic liver diseaseHongze Chen, Muhammad Azhar Nisar, Joud Mulla, et al.
Alcohol, Clinical & Experimental Research|January 5, 2025
Impact of chronic ethanol consumption and SARS-COV-2 on the liver and intestine: A pilot dose-response study in miceSmita Ghare, Dennis Warner, Jeffrey Warner, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
The Journal of Pathology|November 27, 2020
Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activationFengyuan Li, Cuiqing Zhao, Tuo Shao, et al.
Journal of Hepatology|May 28, 2018
Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunctionTuo Shao, Cuiqing Zhao, Fengyuan Li, et al.
Iscience|June 18, 2021
Lemon exosome-like nanoparticles enhance stress survival of gut bacteria by RNase P-mediated specific tRNA decayChao Lei, Yun Teng, Liqing He, et al.
EMBO Molecular Medicine|March 31, 2025
Liver TET1 promotes metabolic dysfunction-associated steatotic liver diseaseHongze Chen, Muhammad Azhar Nisar, Joud Mulla, et al.
Alcohol, Clinical & Experimental Research|January 5, 2025
Impact of chronic ethanol consumption and SARS-COV-2 on the liver and intestine: A pilot dose-response study in miceSmita Ghare, Dennis Warner, Jeffrey Warner, et al.
Pageof 13